« Back to Record
Citation APA

Melsens, K., Vandecasteele, E. E., Deschepper, E., Badot, V., Blockmans, D., Brusselle, G., De Langhe, E., De Pauw, M., Debusschere, C., Decuman, S., Deroo, L., Houssiau, F., Lenaerts, J. J., Piette, Y., Thevissen, K., Vanthuyne, M., Westhovens, R., Wijnant, S., De Keyser, F., & Smith, V. (2018). Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis. Acta Clinica Belgica (English ed. Printed), 73(2), 119-125. doi:10.1080/17843286.2017.1372244


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/272463

Melsens, K., Vandecasteele, E. E., Deschepper, E., Badot, V., Blockmans, D., Brusselle, G., De Langhe, E., De Pauw, M., Debusschere, C., Decuman, S., Deroo, L., Houssiau, F., Lenaerts, J. J., Piette, Y., Thevissen, K., Vanthuyne, M., Westhovens, R., Wijnant, S., De Keyser, F., & Smith, V. (2018). Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis. Acta Clinica Belgica (English ed. Printed), 73(2), 119-125. doi:10.1080/17843286.2017.1372244